Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Airway basal cells show a dedifferentiated KRT17highPhenotype and promote fibrosis in idiopathic pulmonary fibrosis
Benedikt Jaeger, Jonas C. Schupp, Linda Plappert, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

Spatial transcriptomics identifies molecular niche dysregulation associated with distal lung remodeling in pulmonary fibrosis
Annika Vannan, Ruqian Lyu, Arianna L. Williams, et al.
Nature Genetics (2025)
Open Access | Times Cited: 2
Cellular Senescence: Pathogenic Mechanisms in Lung Fibrosis
Tanyalak Parimon, M. Hohmann, Changfu Yao
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6214-6214
Open Access | Times Cited: 76
Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option
Martina Korfei, Poornima Mahavadi, Andreas Guenther
Cells (2022) Vol. 11, Iss. 10, pp. 1626-1626
Open Access | Times Cited: 45
Durable alveolar engraftment of PSC-derived lung epithelial cells into immunocompetent mice
Michael J. Herriges, Maria Yampolskaya, Bibek R. Thapa, et al.
Cell stem cell (2023) Vol. 30, Iss. 9, pp. 1217-1234.e7
Open Access | Times Cited: 29
Precise identification of cell states altered in disease using healthy single-cell references
Emma Dann, Ana-Maria Cujba, Amanda J. Oliver, et al.
Nature Genetics (2023) Vol. 55, Iss. 11, pp. 1998-2008
Open Access | Times Cited: 29
Lung extracellular matrix modulates KRT5+ basal cell activity in pulmonary fibrosis
Richard Hewitt, Franz Puttur, David Gaboriau, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 24
Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine
Ayodeji Adegunsoye, Jonathan A. Kropski, Jürgen Behr, et al.
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 210, Iss. 4, pp. 401-423
Closed Access | Times Cited: 10
Dual Drug Repurposing: The Example of Saracatinib
Raquel Ramos, Nuno Vale
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4565-4565
Open Access | Times Cited: 10
Hypoxia-inducible factor 2 regulates alveolar regeneration after repetitive injury in three-dimensional cellular and in vivo models
A. Scott McCall, Sergey Gutor, Harikrisna Tanjore, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 780
Closed Access | Times Cited: 1
Airway basal stem cell therapy for lung diseases: an emerging regenerative medicine strategy
Xingren Liu, Xin Wang, Xue Wu, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Cloned airway basal progenitor cells to repair fibrotic lung through re-epithelialization
Yu Zhao, Yueqing Zhou, Weipan Zhang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Pharmacological targeting of ECM homeostasis, fibroblast activation, and invasion for the treatment of pulmonary fibrosis
Ioannis Tomos, Paraskevi Kanellopoulou, Dimitris Nastos, et al.
Expert Opinion on Therapeutic Targets (2025)
Closed Access | Times Cited: 1
Involvement of lncRNA MIR205HG in idiopathic pulmonary fibrosis and IL-33 regulation via Alu elements
Tsuyoshi Takashima, Chao Zeng, Eitaro Murakami, et al.
JCI Insight (2025) Vol. 10, Iss. 5
Open Access | Times Cited: 1
Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysis, and Biological Evaluation of Potent Inhibitors
Giuseppe Campiani, Caterina Cavella, J.D. Osko, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 14, pp. 9960-9988
Open Access | Times Cited: 45
Challenges for Clinical Drug Development in Pulmonary Fibrosis
Eric S. White, Matthew J. Thomas, Susanne Stowasser, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 34
Gut microbiota metabolite TMAO promoted lipid deposition and fibrosis process via KRT17 in fatty liver cells in vitro
Fulin Nian, Zhu Chen, Nuyun Jin, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 669, pp. 134-142
Closed Access | Times Cited: 22
Identifying potential biomarkers of idiopathic pulmonary fibrosis through machine learning analysis
Zenan Wu, Huan Chen, Shiwen Ke, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 21
Inhaled nanoparticles for treating idiopathic pulmonary fibrosis by inhibiting honeycomb cyst and alveoli interstitium remodeling
Meng‐Meng Han, Tang Ling, Bin Huang, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 732-745
Closed Access | Times Cited: 8
Gene expression meta-analysis reveals aging and cellular senescence signatures in scleroderma-associated interstitial lung disease
Monica M. Yang, Seoyeon Lee, Jessica Neely, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Fibroblast heterogeneity in pulmonary fibrosis: a new target for therapeutics development?
Konstantin Tsoyi, Iván O. Rosas
European Respiratory Journal (2024) Vol. 63, Iss. 2, pp. 2302188-2302188
Closed Access | Times Cited: 7
The use of cultured human alveolar basal cells to mimic honeycomb formation in idiopathic pulmonary fibrosis
Sabrina Blumer, Petra Khan, Nataliia Artysh, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 6
Idiopathic Pulmonary Fibrosis: From Common Microscopy to Single-Cell Biology and Precision Medicine
Moisés Selman, Annie Pardo
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 209, Iss. 9, pp. 1074-1081
Closed Access | Times Cited: 6
Human Lung Organoids—A Novel Experimental and Precision Medicine Approach
Laura Kühl, Pauline Graichen, Nele von Daacke, et al.
Cells (2023) Vol. 12, Iss. 16, pp. 2067-2067
Open Access | Times Cited: 15
SRC and TKS5 mediated podosome formation in fibroblasts promotes extracellular matrix invasion and pulmonary fibrosis
Ilianna Barbayianni, Paraskevi Kanellopoulou, Dionysiοs Fanidis, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Modeling fibrotic alveolar transitional cells with pluripotent stem cell-derived alveolar organoids
Victoria Ptasinski, Susan J. Monkley, Karolina Öst, et al.
Life Science Alliance (2023) Vol. 6, Iss. 8, pp. e202201853-e202201853
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top